Charco Neurotech
Programme
Accelerate alumni
Sector
Healthcare/Pharma/Biotech
Parkinson’s is a neurodegenerative disorder affecting 10 million people around the world. Despite the best available medical and surgical interventions people with Parkinson’s are often frustrated as they remain significantly limited in their activities. Charco Neurotech (formerly The Moment) developed CUE1, a focused vibrotactile stimulation device for people with Parkinson’s.
CUE1 uses a unique combination of two research-validated vibration-based Parkinson’s therapies; focussed stimulation and cueing. They help with initiation and execution of movement and reduce slowness to smoothen movement. The device also features a medication alert system, which the user can set in their phone. The device discretely reminds the user with a silent vibration when they need to take their medication. The CUE1 application also includes a number of fun games designed to track symptom severity over time. This data can be used by Parkinson’s specialists to help evaluate users during their checkups. All of the participants showed improved movement in our pilot testing by an average of 16%. Participants claimed they felt movement was smoother and better co-ordinated.
Watch a video on Charco Neurotech’s work:
Visit Charco Neurotech website: